Please login to the form below
biologics
This page shows the latest biologics news and features for those working in and with pharma, biotech and healthcare.
Takeda’s Entyvio tops Humira in ulcerative colitis
This landmark study raises the question of the optimal biologic for first-line therapy in patients with moderate to severely active ulcerative colitis.”. ... physicians’ treatment decisions when initiating biologic therapy,” said Takeda’s medical
Latest news
-
FDA begins speedy review of Celgene’s Revlimid combo in lymphoma
The FDA will make its decision by 27 June. Meanwhile, Celgene announced an updated timing on its Biologics License Application (BLA) for its new product luspatercept as a treatment for those
-
Novartis and Syncona back new Swiss biotech Anaveon
re-direction of IL-2 activity in vivo, Anaveon has developed biologic approaches for the highly selective expansion of anti-tumour immune cells.”.
-
AZ says dropping MedImmune will help ‘streamline’ its R&D
Will also drop other candidates that haven’t hit the mark. The demise of the MedImmune brand, which has driven AstraZeneca’s biologics pipeline for more than a decade, will strengthen ... The Gaithersburg, Maryland-headquartered company is the source
-
AbbVie enters BCMA race with Teneobio deal
Teneobio says its “T-cell engaging cancer therapeutics are of the next wave or promising biologics, rivalling CAR-T cell therapy for efficacy, with the added benefit of off-the shelf
-
Ocrevus helps Roche shrug off biosimilars in 2018
Good news after Alzheimer's failure. Roche saw a decline in its European sales last year as biosimilars started to bite its blockbuster biologic drugs, but strong growth for new products ... biologics rolled out in the marketplace.
More from news
Approximately 18 fully matching, plus 522 partially matching documents found.
Latest Intelligence
-
Brain power: fresh approaches to Alzheimer’s drug discovery
These trials aim to accommodate phase 2-ready small molecule or biologic candidates.
-
NHS regional footprints
biologics and joint replacement.
-
Is China ready for a pharmaceutical gold rush?
On top of that, several local firms including Junshi Biosciences, Innovent Biologics and Hengrui Medicine, are developing their own PD-1 I-O treatments that are expected to hit the market ... Innovent Biologics Inc raised HK$3.3bn ($421m) at a valuation
-
AstraZeneca’s oncology renaissance
Imfinzi, competing in the hypercompetitive world of immuno-oncology, was developed by MedImmune, the company’s US-based biologics research division, while the two small molecule drugs were developed in the ... The third area is immuno-oncology (IO)
-
Deal Watch October 2018
non‐biologic product post‐patent loss, highlighting the benefits of biologics in the long term and the complexities of developing and manufacturing them. ... $307m. Samsung Bioepis/. Merck &Co. Lusduna Nexvue follow‐on biologic. Termination. $155m.
More from intelligence
Approximately 2 fully matching, plus 74 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Bahija has more than 25 years of international leadership experience within the pharmaceutical industry, and joins Immunocore from AstraZeneca, where she has served as President of MedImmune, its global biologics research ... A champion for science and
-
BMS appoints new commercial leader, Davies joins Eisai and more
Commenting on her appointment, Schuermans said: “Sobi has unique capabilities, a heritage in biologics manufacturing, development and supply, and a very exciting future within the rare disease space.
-
Industry appointments
Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma
-
Nabriva Therapeutics appoints chief medical officer
medical affairs for small molecules and biologics.
-
Ipsen appoints Aidan Murphy as EVP, technical operations
He is promoted from senior VP biologics development and manufacturing. Ipsen has added to its executive leadership team in the form of Aidan Murphy, who becomes the biopharma’s executive vice ... being senior vice president biologics development and
More from appointments
Approximately 7 fully matching, plus 46 partially matching documents found.
Latest from PMHub
-
News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)
A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.
-
NHS medicines optimisation milestone
Consequently, it is hugely significant to the NHS’s best value biologics agenda. ... A key issue to consider in this regard is how patients receive biologic medications.
-
OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months. The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and
-
It’s all about patient outcomes… right?
a novel biologic agent. ... the roll-out of the novel biologic agent was conducted in a manner that was sensitive to the PCP/specialist interaction observed, ensured smooth communications and optimised patient outcomes.
-
Biotech: it's a people business
Biologic therapies have become a central part of modern day medicine and a key part of biotech and pharma portfolios.
More from PMHub
Approximately 7 fully matching, plus 34 partially matching documents found.
Featured jobs
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Digital Account Director
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Account Director, Medical Education
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Health Consultant - Brand Comms
-
Competitive Salary
- Scientific Director – Medical Communications
-
Salary TBC
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
-
Senior Medical Writer
-
Salary TBC
- Senior Account Manager, Medical Communications, London
-
Excellent package
Subscribe to our email news alerts
- Fishawack acquires Dudnyk
- GSK’s myeloma drug hits target, prompting rapid filing pledge
- Winners of the HSJ Partnership Awards 2019 unveiled
- 50 questions for delivering an exceptional healthcare brand experience
- Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity
- The brand strategy revolution
PMHub
Synergy Vision
Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...
Latest intelligence
- 50 questions for delivering an exceptional healthcare brand experience
- Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
- The brand strategy revolution
- Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
